809 related articles for article (PubMed ID: 15113051)
1. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
[TBL] [Abstract][Full Text] [Related]
2. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
[TBL] [Abstract][Full Text] [Related]
3. [Pulmonary involvement in sclerodermia].
Paone G; Di Michele L; Mattia P; Tonnarini R; Lucifora V; Fiorucci F
Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
[TBL] [Abstract][Full Text] [Related]
4. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
5. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
[TBL] [Abstract][Full Text] [Related]
6. Esophageal involvement and pulmonary manifestations in systemic sclerosis.
Marie I; Dominique S; Levesque H; Ducrotté P; Denis P; Hellot MF; Courtois H
Arthritis Rheum; 2001 Aug; 45(4):346-54. PubMed ID: 11501722
[TBL] [Abstract][Full Text] [Related]
7. Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis.
Bezante GP; Rollando D; Sessarego M; Panico N; Setti M; Filaci G; Molinari G; Balbi M; Cutolo M; Barsotti A; Indiveri F; Ghio M
J Rheumatol; 2007 Dec; 34(12):2431-7. PubMed ID: 17985401
[TBL] [Abstract][Full Text] [Related]
8. [Patterns of ventricular late potentials in systemic sclerosis: a noninvasive method in the study of cardiac involvement].
Pignone A; Matucci-Cerinic M; Becucci A; de Leonardis V; Lombardi A; Fabiani D; Bernardo P; Scaletti C; Carossino AM; Cagnoni M
Ann Ital Med Int; 1994; 9(3):141-5. PubMed ID: 7946889
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the functional parameters in scleroderma cases with pulmonary involvement.
Celebi Sözener Z; Karabıyıkoğlu G; Düzgün N
Tuberk Toraks; 2010; 58(3):235-41. PubMed ID: 21038133
[TBL] [Abstract][Full Text] [Related]
10. Outcome measures for heart involvement in systemic sclerosis.
Allanore Y; Meune C; Kahan A
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v51-3. PubMed ID: 18784146
[TBL] [Abstract][Full Text] [Related]
11. [Strategy for early diagnosis of lung involvement in systemic scleroderma].
Diot E; Valat C; Boissinot E; Giraudeau B; Asquier E; Guilmot JL; Lemarié E; Diot P
Rev Mal Respir; 2000 Dec; 17(6):1073-80. PubMed ID: 11217502
[TBL] [Abstract][Full Text] [Related]
12. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies.
Meune C; Vignaux O; Kahan A; Allanore Y
Arch Cardiovasc Dis; 2010 Jan; 103(1):46-52. PubMed ID: 20142120
[TBL] [Abstract][Full Text] [Related]
13. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study.
Tzelepis GE; Kelekis NL; Plastiras SC; Mitseas P; Economopoulos N; Kampolis C; Gialafos EJ; Moyssakis I; Moutsopoulos HM
Arthritis Rheum; 2007 Nov; 56(11):3827-36. PubMed ID: 17968945
[TBL] [Abstract][Full Text] [Related]
14. Management of scleroderma in a New Zealand tertiary rheumatology centre: emphasis on pulmonary complications.
Ng K; Gow P
N Z Med J; 2007 May; 120(1254):U2537. PubMed ID: 17515941
[TBL] [Abstract][Full Text] [Related]
15. Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis.
Lock G; Pfeifer M; Straub RH; Zeuner M; Lang B; Schölmerich J; Holstege A
Am J Gastroenterol; 1998 Mar; 93(3):341-5. PubMed ID: 9517636
[TBL] [Abstract][Full Text] [Related]
16. Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography.
Rodríguez-Reyna TS; Morelos-Guzman M; Hernández-Reyes P; Montero-Duarte K; Martínez-Reyes C; Reyes-Utrera C; Vazquez-La Madrid J; Morales-Blanhir J; Núñez-Álvarez C; Cabiedes-Contreras J
Rheumatology (Oxford); 2015 Apr; 54(4):647-54. PubMed ID: 25239881
[TBL] [Abstract][Full Text] [Related]
17. Systemic sclerosis and cardiac dysfunction: evolving concepts and diagnostic methodologies.
Allanore Y; Meune C; Kahan A
Curr Opin Rheumatol; 2008 Nov; 20(6):697-702. PubMed ID: 18946331
[TBL] [Abstract][Full Text] [Related]
18. Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis.
Kobayashi H; Yokoe I; Hirano M; Nakamura T; Nakajima Y; Fontaine KR; Giles JT; Kobayashi Y
J Rheumatol; 2009 Jan; 36(1):106-12. PubMed ID: 19040307
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary functions in children with progressive systemic sclerosis.
Garty BZ; Athreya BH; Wilmott R; Scarpa N; Doughty R; Douglas SD
Pediatrics; 1991 Dec; 88(6):1161-7. PubMed ID: 1956732
[TBL] [Abstract][Full Text] [Related]
20. Cardiac complications of systemic sclerosis.
Kahan A; Coghlan G; McLaughlin V
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii45-8. PubMed ID: 19487224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
